| Name | ceclazepide |
|---|---|
| Synonyms |
99B5ZR9276
2,2-Dimethyl-4-[(3R)-3-({[3-(methylamino)phenyl]carbamoyl}amino)-2-oxo-5-(2-pyridinyl)-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]-3-oxobutyl acetate ceclazepide Urea, N-[(3R)-1-[4-(acetyloxy)-3,3-dimethyl-2-oxobutyl]-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1H-1,4-benzodiazepin-3-yl]-N'-[3-(methylamino)phenyl]- |
| Description | A potent, selective cholecystokinin receptor CCK2 antagonist for treatment of gastroesophageal reflux disease (GERD). Other Indication Phase 1 Clinical |
|---|---|
| References | References View Related Products by Target Cholecystokinin Receptor Other Indication |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 773.4±60.0 °C at 760 mmHg |
| Molecular Formula | C30H32N6O5 |
| Molecular Weight | 556.612 |
| Flash Point | 421.5±32.9 °C |
| Exact Mass | 556.243408 |
| LogP | 3.16 |
| Vapour Pressure | 0.0±2.7 mmHg at 25°C |
| Index of Refraction | 1.633 |